Live feed
Filing
SC 13D
SC 13D0001193125-20-219199·Kalaris Therapeutics, Inc.
Schedule 13D ownership disclosure
ALLOVIR INC
Security class unavailable · CUSIP: 019818103
Event date: 2020-08-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 20.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-219199
- Form type
- SC 13D
- Filer
- Kalaris Therapeutics, Inc.
- CIK
- CIK 1754068
- Filed
- Aug 13, 2020
- Reporting period
- Aug 03, 2020
- Description
- Schedule 13D beneficial ownership